Health Catalyst, INC 10-K annual reports

Health Catalyst, Inc. filed an amendment to its 2025 Annual Report to provide required disclosures regarding executive compensation, corporate governance, and director information.

Health Catalyst, Inc. reported a significant net loss of $178.0 million in 2025, primarily driven by a $105.4 million goodwill impairment, despite a modest 1% revenue increase to $311.1 million.

Health Catalyst files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and accountant fees.

Health Catalyst's 2024 10-K filing reveals a year of revenue growth amidst ongoing macroeconomic challenges and strategic restructuring.

Health Catalyst has filed an amendment to its annual report to correct omissions in certifications related to internal control over financial reporting.

Health Catalyst, Inc. released its 2023 10-K filing, outlining its financial results, strategic initiatives, and risk factors.